RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Regenerative Medical Technology Group Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026
- Market cap
- $497.25K
- P/E (TTM)
- –
- Dividend yield
- –
Regenerative Medical Technology Group Inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|
| Global Stem Cells Group [Member] | $5.10M | – | – | – | – | – | 100.0% | – |
| Product supplies [Member] | $2.02M | $1.75M | $1.33M | $866.10K | $209.71K | – | 39.7% | +15.8% |
| Patient procedures [Member] | $1.87M | $1.37M | $319.00K | $221.26K | – | – | 36.8% | +36.7% |
| Training [Member] | $1.13M | $809.65K | $599.43K | $279.40K | $112.97K | – | 22.1% | +39.0% |
| Equipment [Member] | $75.84K | $177.23K | $162.37K | $163.46K | $115.21K | – | 1.5% | -57.2% |
| Coins and banknotes [Member] | – | – | – | – | $31.67K | $55.08K | – | – |
| Total Revenue [Member] | – | – | – | – | $185.25K | – | – | – |
By region
From the segment and revenue-disaggregation notes of Regenerative Medical Technology's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.